Binding modes of thioflavin T and Congo red to the fibril structure of amyloid-β(1–42)
- 1 June 2020
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 56 (55) , 7589-7592
Abstract
Binding modes for the amyloid-β(1–42) fibril fluorescent dyes thioflavin T and Congo red were predicted by molecular dynamics simulations and binding free energy calculations. Both probes bind on the fibril surface to primarily hydrophobic grooves, with their long axis oriented almost parallel to the fibril axis. The computed binding affinities are in agreement with experimental values. The binding modes also explain observables from previous structural studies and, thus, provide a starting point for the systematic search and design of novel molecules, which may improve in vitro diagnostics for Alzheimer's disease.Keywords
Funding Information
- Forschungszentrum Jülich (HKF7)
This publication has 43 references indexed in Scilit:
- A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brainNature Reviews Neurology, 2017
- Thioflavin T as an amyloid dye: fibril quantification, optimal concentration and effect on aggregationRoyal Society Open Science, 2017
- The amyloid hypothesis of Alzheimer's disease at 25 yearsEMBO Molecular Medicine, 2016
- Alzheimer's diseaseNature Reviews Disease Primers, 2015
- Emerging Concepts in Alzheimer's DiseaseAnnual Review of Pathology: Mechanisms of Disease, 2015
- Self-propagation of pathogenic protein aggregates in neurodegenerative diseasesNature, 2013
- Interaction of Thioflavin T with Amyloid Fibrils: Stoichiometry and Affinity of Dye Binding, Absorption Spectra of Bound DyeThe Journal of Physical Chemistry B, 2011
- The propagation of prion-like protein inclusions in neurodegenerative diseasesTrends in Neurosciences, 2010
- Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils—current statusJournal of Chemical Biology, 2009
- Radioligand Development for PET Imaging of β-Amyloid (Aβ)-Current StatusCurrent Medicinal Chemistry, 2007